Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Pardi

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Vaccines|June 2, 2021
mRNA Innovates the Vaccine FieldNorbert Pardi
Nature Reviews. Drug Discovery|October 4, 2024
mRNA vaccines for infectious diseases - advances, challenges and opportunitiesNorbert Pardi, Florian Krammer
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Measuring the Adjuvant Activity of RNA VaccinesNorbert Pardi, Drew Weissman
Nature|June 24, 2026
Immunological mechanisms of mRNA vaccines for infectious diseasesMichela Locci, Norbert Pardi
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Nucleoside Modified mRNA Vaccines for Infectious DiseasesNorbert Pardi, Drew Weissman
Annual Review of Medicine|October 20, 2021
mRNA Vaccines in the COVID-19 Pandemic and BeyondMichael J Hogan, Norbert Pardi
Vaccines|April 5, 2018
New Kids on the Block: RNA-Based Influenza Virus VaccinesFrancesco Berlanda Scorza, Norbert Pardi
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2020
Vaccination with Messenger RNA: A Promising Alternative to DNA VaccinationIstván Tombácz, Drew Weissman, Norbert Pardi
Biologia Futura|May 22, 2023
Innovation in the 21st century: following the footsteps of Katalin KarikóCsaba Deák, Norbert Pardi, Ádám Miklósi
Current Opinion in Immunology|April 4, 2020
Recent advances in mRNA vaccine technologyNorbert Pardi, Michael J Hogan, Drew Weissman
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Vaccines|June 2, 2021
mRNA Innovates the Vaccine FieldNorbert Pardi
Nature Reviews. Drug Discovery|October 4, 2024
mRNA vaccines for infectious diseases - advances, challenges and opportunitiesNorbert Pardi, Florian Krammer
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Measuring the Adjuvant Activity of RNA VaccinesNorbert Pardi, Drew Weissman
Nature|June 24, 2026
Immunological mechanisms of mRNA vaccines for infectious diseasesMichela Locci, Norbert Pardi
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Nucleoside Modified mRNA Vaccines for Infectious DiseasesNorbert Pardi, Drew Weissman
Annual Review of Medicine|October 20, 2021
mRNA Vaccines in the COVID-19 Pandemic and BeyondMichael J Hogan, Norbert Pardi
Vaccines|April 5, 2018
New Kids on the Block: RNA-Based Influenza Virus VaccinesFrancesco Berlanda Scorza, Norbert Pardi
Methods in Molecular Biology (Clifton, N.J.)|August 23, 2020
Vaccination with Messenger RNA: A Promising Alternative to DNA VaccinationIstván Tombácz, Drew Weissman, Norbert Pardi
Biologia Futura|May 22, 2023
Innovation in the 21st century: following the footsteps of Katalin KarikóCsaba Deák, Norbert Pardi, Ádám Miklósi
Current Opinion in Immunology|April 4, 2020
Recent advances in mRNA vaccine technologyNorbert Pardi, Michael J Hogan, Drew Weissman
Pageof 15